Short Interest in Centogene (NASDAQ:CNTG) Grows By 5.3%

Centogene (NASDAQ:CNTG) was the target of a large increase in short interest in March. As of March 31st, there was short interest totalling 11,900 shares, an increase of 5.3% from the March 15th total of 11,300 shares. Approximately 0.1% of the company’s stock are sold short. Based on an average trading volume of 44,800 shares, the short-interest ratio is currently 0.3 days.

Centogene Trading Down 2.0 %

Shares of NASDAQ CNTG traded down $0.01 during mid-day trading on Tuesday, reaching $0.48. 82,324 shares of the company’s stock were exchanged, compared to its average volume of 45,377. Centogene has a 52 week low of $0.46 and a 52 week high of $2.52. The firm has a 50-day moving average price of $0.76 and a two-hundred day moving average price of $1.03.

Centogene Company Profile

Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases.